ARAlexandra de Azevedo da Rocha

Alexandra de Azevedo da Rocha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra de Azevedo da Rocha has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conserved gene clusters in entomopathogenic filamentous fungi

    by Alexandra de Azevedo da Rocha, Charley Christian Staats

    Entomopathogenic filamentous fungi from the Order Hypocreales are studied for biological pest control due to their ability to infect arthropods. Their biotechnological potential lies in the production of secondary metabolites (SMs), encoded by biosynthetic gene clusters (BGCs), which are crucial for the fungal life cycle and infection. Due to the different roles played by SMs in fungi, the in-depth study of these molecules has increased over the last years. Considering the proven biotechnological importance of species of the genus Beauveria have already shown, we performed an in-silico analysis of BGCs of the species from the order Hypocreales to uncover potential conserved pathways and find new candidates for biological pest control. A total of 295 genome sequences were analyzed using antiSMASH, allowing the identification of 12,968 BGCs. Conservation analysis was performed using BiG-SCAPE, which could group these BGCs into 2,127 biosynthetic gene families. Despite the presence of conserved gene clusters, especially within the same genus, when the comparison of BGCs was performed within the order, a large part of them is orphaned, highlighting the great diversity of BGCs and consequently the chemodiversity of fungal species. Our approach helps to uncover new molecules that may provide new biotechnological tools.

  • Open Access

    All you need is fungi: Exploring secondary metabolites as a source of novel amoebicidal agents

    by Maria Eduarda Deluca João, Deisiane dos Santos Moura, Alexandra de Azevedo da Rocha, Matheus Lopes Braga, Henrique R.M. Antoniolli, Mauren Larangeira Ramos, Sofia Dietrich Loch, Charley Christian Staats

    Free-living amoebae (FLAs) of the genus Acanthamoeba are opportunistic protozoa found in diverse environments. They can cause granulomatous amoebic encephalitis, especially in immunocompromised individuals, and Acanthamoeba keratitis, a painful corneal infection frequently associated with contact lens wearers. Effective treatments for Acanthamoeba infections are limited, with nitroimidazoles as the main pharmacological option, a class of drugs generally associated with side effects. Given the limited availability of vaccines and the low efficacy of existing drugs, the search for new therapeutic strategies is crucial. Interactions between fungi and predatory amoebae have driven the production of defensive fungal secondary metabolites (SMs) with potent amoebicidal properties. The evolutionary pressure from predatory amoebae has equipped fungi, particularly from the Aspergillus, Beauveria, and Fusarium genera, to produce a wide variety of defensive bioactive compounds, including non-ribosomal peptides, polyketides, and terpenes. Some examples of fungal-derived SMs include cephalosporins, mycophenolic acid, griseofulvin, pleuromutilins and lovastatin. Furthermore, gliotoxin and trypacidin from Aspergillus fumigatus exhibit amoebicidal activity by impairing key protozoan functions like phagocytosis. These findings highlight the potential of fungal SMs as novel amoebicidal agents. Exploring fungal biodiversity could lead to the discovery of innovative medicines, harnessing natural compounds to combat infections caused by Acanthamoeba species and other protozoan pathogens.

  • Gene clusters potentially involved in the virulence of Metarhizium anisopliae

    by Mauren Larangeira Ramos, Maria Eduarda Deluca João, Francisco Nunes Mielke, Alexandra de Azevedo da Rocha, Augusto Schrank, Livia Kmetzsch, Charley Christian Staats